DSM-Firmenich AG

As of June 30, 2026, DSM Firmenich AG carries a market capitalization of 23.38B, placing it among publicly traded companies globally. Its enterprise value stands at 28.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

DSM Firmenich AG's next confirmed earnings release is scheduled for February 18, 2027.

As of June 30, 2026, DSM Firmenich AG has 2.48B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, DSM Firmenich AG maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 23, 2026, DSM Firmenich AG's stock has gained approximately 39.04% over the past 52 weeks. The 50-day moving average sits at 11.00, while the 200-day moving average is 8.89.

As of June 30, 2026, DSM Firmenich AG holds 2.64B in cash and equivalents against 7.73B in total debt, resulting in a net debt position of 5.15B. Total book value stands at 20.37B, with working capital of 4.87B providing operational flexibility.